Whitehawk Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Gardner Joseph H. | President | Purchase | 5,000 | $0.81 | $4,050 | 453,019 | Jul 10, 2019 |
| Gardner Joseph H. | President | Purchase | 5,000 | $0.90 | $4,500 | 448,019 | Jul 3, 2019 |
| NOVARTIS AG | — | Sale | 138,704 | $1.03 | $142,865 | 4,049,804 | Apr 25, 2019 |
| NOVARTIS AG | — | Sale | 27,554 | $1.03 | $28,381 | 4,768,007 | Apr 22, 2019 |
| Novartis Bioventures Ltd | — | Sale | 57,438 | $1.08 | $62,033 | 4,862,363 | Apr 15, 2019 |
| Novartis Bioventures Ltd | — | Sale | 32,991 | $1.01 | $33,321 | 5,060,031 | Apr 8, 2019 |
| Novartis Bioventures Ltd | — | Sale | 47,900 | $1.01 | $48,379 | 5,145,208 | Apr 3, 2019 |
| Novartis Bioventures Ltd | — | Sale | 116,909 | $0.95 | $111,064 | 5,302,895 | Mar 29, 2019 |
| NOVARTIS AG | — | Sale | 50,749 | $0.99 | $50,242 | 5,571,739 | Mar 26, 2019 |
| Satter Muneer A | — | Purchase | 20,000 | $2.20 | $44,000 | 5,578,017 | Jan 10, 2019 |
| Satter Muneer A | — | Purchase | 20,000 | $2.08 | $41,600 | 5,518,017 | Jan 7, 2019 |
| Satter Muneer A | — | Purchase | 20,000 | $1.72 | $34,400 | 5,458,017 | Jan 2, 2019 |
| Satter Muneer A | — | Purchase | 20,000 | $1.69 | $33,800 | 5,418,017 | Dec 27, 2018 |
| Satter Muneer A | — | Purchase | 20,000 | $1.92 | $38,400 | 5,358,017 | Dec 20, 2018 |
| Satter Muneer A | — | Purchase | 20,000 | $2.05 | $41,000 | 5,278,017 | Dec 13, 2018 |
| Gardner Joseph H. | President | Gift | 150,000 | — | — | 150,000 | Dec 12, 2018 |
| Satter Muneer A | — | Purchase | 20,000 | $2.13 | $42,600 | 5,238,017 | Dec 11, 2018 |
| Satter Muneer A | — | Purchase | 20,000 | $2.10 | $42,000 | 5,178,017 | Dec 3, 2018 |
| Satter Muneer A | — | Purchase | 20,000 | $1.98 | $39,600 | 5,138,017 | Nov 28, 2018 |
| HOFFMAN STEPHEN J | Chief Executive Officer | Purchase | 30,000 | $2.01 | $60,300 | 31,967 | Nov 9, 2018 |
| Castelein Caley | — | Other | 268,987 | — | — | 279,907 | Sep 24, 2018 |
| NOVARTIS AG | — | Sale | 5,300 | $3.90 | $20,670 | 5,800,250 | Aug 20, 2018 |
| ORBIMED ADVISORS LLC | — | Purchase | 777,500 | $3.85 | $2,993,375 | 5,193,946 | Jun 28, 2018 |
| Khuong Chau Quang | — | Purchase | 777,500 | $3.85 | $2,993,375 | 5,193,946 | Jun 28, 2018 |
| Satter Muneer A | — | Purchase | 1,818,182 | $3.85 | $7,000,001 | 5,078,017 | Jun 28, 2018 |
| Satter Muneer A | — | Purchase | 4,000 | $4.85 | $19,400 | 3,258,835 | Mar 23, 2018 |
| Satter Muneer A | — | Purchase | 5,400 | $4.97 | $26,838 | 3,254,835 | Mar 19, 2018 |
| Castelein Caley | — | Other | 10,920 | — | — | 10,920 | Dec 22, 2017 |
| Dalal Anupam | — | Other | 7,882 | — | — | — | Dec 22, 2017 |
| Castelein Caley | — | Purchase | 400,000 | $5.00 | $2,000,000 | 1,611,408 | Mar 15, 2017 |
| Khuong Chau Quang | — | Purchase | 762,995 | $5.00 | $3,814,975 | 4,416,446 | Mar 15, 2017 |
| PETERS KEVIN G. | Chief Scientific Officer | Purchase | 3,642 | $5.00 | $18,210 | 320,536 | Mar 15, 2017 |
| ISALY SAMUEL D | — | Purchase | 762,995 | $5.00 | $3,814,975 | 4,416,446 | Mar 15, 2017 |
| Gardner Joseph H. | See Remarks | Purchase | 99,996 | $5.00 | $499,980 | 593,019 | Mar 15, 2017 |
| WEISS PAUL M | — | Purchase | 272,302 | $5.00 | $1,361,510 | 1,576,167 | Mar 15, 2017 |
| Novartis Bioventures Ltd | — | Purchase | 560,000 | $5.00 | $2,800,000 | 5,805,550 | Mar 15, 2017 |
| Satter Muneer A | — | Purchase | 1,120,000 | $5.00 | $5,600,000 | 3,241,835 | Mar 15, 2017 |